https://staging.aspeya.com/news-resources/ 2026-05-29T14:27:41+00:00 https://staging.aspeya.com/2025/03/04/aspeya-a-new-name-for-science-insight-and-innovation/ 2026-02-11T09:18:39+00:00 https://staging.aspeya.com/2025/08/14/verdeya-a-new-chapter-in-addressing-unmet-needs-with-best-in-class-cannabinoid-products/ 2026-02-11T09:18:39+00:00 https://staging.aspeya.com/2024/09/17/vectura-fertin-pharma-announces-agreement-for-sale-of-vectura-group-to-molex/ 2026-02-11T09:18:39+00:00 https://staging.aspeya.com/2024/08/01/aurora-cannabis-and-vectura-fertin-pharma-announce-launch-of-novel-luo-cbd-lozenge/ 2026-02-11T09:18:39+00:00 https://staging.aspeya.com/2024/09/09/aurora-cannabis-and-vectura-fertin-pharma-announce-launch-of-novel-luo-cbd-lozenge-2/ 2026-02-11T09:18:39+00:00 https://staging.aspeya.com/2026/05/26/aspeya-announces-first-patient-first-visit-fpfv-in-two-clinical-trials-supporting-development-of-asy202-for-the-acute-treatment-of-migraine/ 2026-05-29T14:27:41+00:00